Morningside is a venture capital firm based in the greater Boston area, specializing in investments in companies that focus on innovative science and technology. Established in 1986 as a family office for the Chan family, Morningside emphasizes a long-term approach to company-building and maintains a strong commitment to ethical practices. The firm is staffed by a team of experienced investment professionals with expertise in various sectors, including life sciences, digital health, artificial intelligence, materials, and technology. In addition to its investment activities, Morningside is dedicated to philanthropic efforts, supporting education, research, and healthcare initiatives such as the Harvard T.H. Chan School of Public Health, UMass Chan Medical School, and the MIT Morningside Academy for Design.
SimpliFed is a telehealth company that offers virtual breastfeeding support and broader maternal care services to new and pregnant parents. Founded in 2020, it addresses challenges such as sleep deprivation, uncertainty, and complex infant nutrition questions. The company builds trusted relationships with parents and partners with healthcare payers and providers to deliver a comprehensive maternal health operating system covering pregnancy, postpartum, and baby feeding.
Huckleberry Labs
Series A in 2021
Huckleberry makes behavioral expertise accessible and affordable to all families by combining AI with human experts, starting with children's sleep.
Cognoa
Series A in 2019
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics. Its AI technology platform enables earlier diagnosis and treatment of conditions like autism, ADHD, and anxiety, empowering parents and healthcare providers to improve outcomes for children.
Cognoa
Series A in 2016
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics. Its AI technology platform enables earlier diagnosis and treatment of conditions like autism, ADHD, and anxiety, empowering parents and healthcare providers to improve outcomes for children.
Cognoa
Series A in 2013
Cognoa is a pediatric behavioral health company developing digital diagnostics and therapeutics. Its AI technology platform enables earlier diagnosis and treatment of conditions like autism, ADHD, and anxiety, empowering parents and healthcare providers to improve outcomes for children.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.